Nachrichten zur Amgen Inc. Aktie

Amgen Aktie: Jetzt wird es für Anleger brenzlig!

Bad Marienberg (www.aktiencheck.de) - Die Amgen-Aktie (ISIN: US0311621009, WKN: 867900, Ticker-Symbol: AMG, NASDAQ-Symbol: AMGN) steht vor einer spannenden Bewährungsprobe. Barclays…

Amgen Aktie: Repatha gewinnt an Dynamik - Analysten werden optimistischer

New York (www.aktiencheck.de) - Amgen-Aktienanalyse von Oppenheimer:Die Analysten von Oppenheimer stufen die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900,…

ROUNDUP: Amgen wird erneut etwas optimistischer - Anleger hoch erfreut

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat nach einem starken zweiten Quartal erneut die…

Amgen gains after strong quarterly results and continued product momentum

Amgen Inc (NASDAQ:AMGN, XETRA:AMG) shares rose about 4% on Wednesday after the biotechnology company reported second quarter 2026 results that…

Amgen wird erneut etwas optimistischer - Anleger unbeeindruckt

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat nach einem starken zweiten Quartal erneut die…

AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite biosimilar pressure…

Amgen (AMGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter…

Amgen (AMGN) Q2 Earnings and Revenues Surpass Estimates

Amgen (AMGN) delivered earnings and revenue surprises of +12.32% and +6.52%, respectively, for the quarter ended June 2026. Do the…

Are These 5 Pharma Stocks Set to Surpass Q2 Earnings Forecasts?

Amgen, Pfizer, Eli Lilly, Merck and Novo Nordisk are set to report Q2 results this week after a strong start…

Amgen hit by cybersecurity incident, sensitive data stolen

…

Amgen discloses data breach, says patient information was stolen

Amgen discloses data breach, says patient information was stolen…

Amgen Q2 Earnings Preview: Will the Beat Streak Continue?

Amgen heads into Q2 earnings with a history of beats as investors watch key drug sales trends and seek updates…

Watch Out, Eli Lilly and Novo Nordisk: Amgens Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and Its Coming for Your Patients

Will this pharma company become a new leader in the weight loss market?…

Amgen (AMGN) Stock Dips While Market Gains: Key Facts

Amgen (AMGN) closed the most recent trading day at $366.44, moving 2.06% from the previous trading session.…

Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock?

Amgen (AMGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This…

Judge blocks Colorados first-of-its-kind price cap on Amgens Enbrel

A federal judge on Wednesday blocked Colorado from capping the price of Amgens blockbuster arthritis drug Enbrel, a first-of-its-kind ?move…

Amgen (AMGN) Increases Despite Market Slip: Heres What You Need to Know

In the most recent trading session, Amgen (AMGN) closed at $351.93, indicating a +1.42% shift from the previous trading day.…

Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both…

Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?

Amgen posts strong profits and cash flow, while NovoCure pursues growth with a direct-to-patient cancer therapy model and leaner balance…

Amgen Aktie: Mizuho hebt Kursziel an - warum das trotzdem kein Kaufsignal ist

Bad Marienberg (www.aktiencheck.de) - Amgen: Kursziel steigt, aber Mizuho warnt vor begrenztem PotenzialDie Aktie von Amgen Inc. (ISIN: US0311621009, WKN:…

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Amgen taps Duke Research Institute to reevaluate disputed Tavneos data

Amgen taps Duke Research Institute to reevaluate disputed Tavneos data…

Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Amgen (AMGN) stood at $337.5, denoting a -2.05% move from the preceding…

Amgen Aktienanalyse: Revolutionäre Krebszulassung könnte den nächsten Wachstumsmotor zünden

Bad Marienberg (www.aktiencheck.de)Amgen Aktie vor neuem Wachstumsschub? EU-Zulassung von IMDYLLTRA eröffnet Milliardenchance im Kampf gegen LungenkrebsDie Aktie von Amgen Inc.…

Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?

NVO and AMGN square off as GLP-1 leadership, pipeline depth and diversification shape a compelling healthcare stock comparison.…

The Zacks Analyst Blog Highlights RTX, Wells Fargo, Amgen, Daily Journal and Tandy Leather

RTX, Wells Fargo and Amgen headline Zacks research as aerospace demand, banking shifts and drug launches drive outlooks.…

Amgens Growth Engine Is Just Getting Started

…

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Amgen stock falls after Kissei warns on Tavneos liver risks

Amgen stock falls after Kissei warns on Tavneos liver risks…

Amgen Aktie: Seltene Krankheiten und starke Studiendaten treiben Fantasie

Minneapolis (www.aktiencheck.de) - Amgen-Aktienanalyse von Piper Sandler:Die Analysten von Piper Sandler haben das Kursziel für die Aktie von Amgen Inc.…

Amgen Aktie: Neue Kaufchance nach dem Kursrücksetzer

New York (www.aktiencheck.de) - Amgen-Aktienanalyse von Freedom Capital Markets:Freedom Broker habe die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900,…

CHRS Q1 2026 Earnings Transcript

Image source: The Motley Fool.DATEMonday, May 11, 2026 at 5 p.m. ETCALL PARTICIPANTSChief Executive Officer — Dennis M. LanfearChief Medical…

Amgen’s New Puerto Rico Biologics Investment Might Change The Case For Investing In Amgen (AMGN)

In early May 2026, Amgen announced a further US$300.00 million investment in its U.S. manufacturing network, expanding its large biologics…

Gevo (GEVO) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DATEThursday, May 7, 2026 at 4:30 p.m. ETCall participantsChief Executive Officer — Paul D. BloomChief Financial…

IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading

Global IgG4-related disease market sees growth due to increased research funding and development of targeted therapies. This rare autoimmune condition…

dpa-AFX ProFeed